港股異動 | 中糧肉食(1610.HK)午後漲幅擴大至11% 兩日大漲超22%
格隆匯4月17日丨中糧肉食(1610.HK)午後漲幅擴大至10.78%,現報2.57港元,暫成交2.4億港元,最新總市值100.3億港元。近日股價累升,兩日大漲超22%。公司日前公佈,1季度生豬出欄量30.8萬頭,環比增長15%,商品豬均價同比大增207.1%。此外公司2019年度由虧轉盈15.74億元,生豬養殖、生鮮豬肉、肉製品營業收入亦同比增長。天風證券報告稱,隨着公司屠宰產能的持續釋放以及品牌生鮮的持續拓展,公司生鮮豬肉業務有望持續增長,同時進一步延伸產業鏈持續提升公司的盈利能力。目前公司業績迎來釋放期,給予目標價為3.9港元,維持“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.